-
1
المؤلفون: Christian Knoop, Jochen H.O. Hoffmann, Alexander Enk, Eva Hadaschik
المصدر: Journal of Dermatological Science. 76:180-185
مصطلحات موضوعية: Adult, Male, musculoskeletal diseases, medicine.medical_specialty, Kaplan-Meier Estimate, Dermatology, Antibodies, Monoclonal, Humanized, Biochemistry, Disease-Free Survival, Receptors, Tumor Necrosis Factor, Etanercept, Predictive Value of Tests, Psoriasis Area and Severity Index, Internal medicine, Psoriasis, medicine, Adalimumab, Clinical endpoint, Humans, Outpatient clinic, skin and connective tissue diseases, Molecular Biology, Retrospective Studies, Tumor Necrosis Factor-alpha, business.industry, Retrospective cohort study, Middle Aged, medicine.disease, Surgery, Antibodies, Antinuclear, Immunoglobulin G, Female, Tumor necrosis factor alpha, business, Immunosuppressive Agents, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::025fefa8e9922a8c1237084b767aded0Test
https://doi.org/10.1016/j.jdermsci.2014.09.003Test -
2
المؤلفون: David Moreno-Ramírez, Teresa Ojeda-Vila, Lara Ferrándiz
المصدر: American Journal of Clinical Dermatology. 15:543-549
مصطلحات موضوعية: Male, musculoskeletal diseases, medicine.medical_specialty, Anti-Inflammatory Agents, Dermatology, Antibodies, Monoclonal, Humanized, Drug Administration Schedule, Receptors, Tumor Necrosis Factor, Etanercept, Cohort Studies, Pharmacotherapy, Psoriasis, Internal medicine, medicine, Adalimumab, Humans, skin and connective tissue diseases, Retrospective Studies, business.industry, Retrospective cohort study, General Medicine, Middle Aged, medicine.disease, Surgery, Treatment Outcome, Immunoglobulin G, Relative risk, Cohort, Female, business, Follow-Up Studies, Cohort study, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e33f64f08ff2425b0f9cdd06ecb80fe6Test
https://doi.org/10.1007/s40257-014-0095-3Test -
3
المؤلفون: B.T. Snodgrass, L. Hsu, April W. Armstrong
المصدر: British Journal of Dermatology. 170:261-273
مصطلحات موضوعية: musculoskeletal diseases, medicine.medical_specialty, Dermatology, Antibodies, Monoclonal, Humanized, Antibodies, Receptors, Tumor Necrosis Factor, Etanercept, Efficacy, Biological Factors, immune system diseases, Psoriasis Area and Severity Index, Internal medicine, Psoriasis, Ustekinumab, medicine, Adalimumab, Humans, Immunologic Factors, skin and connective tissue diseases, business.industry, Antibodies, Monoclonal, medicine.disease, Infliximab, Methotrexate, Immunoglobulin G, Immunology, Dermatologic Agents, business, Immunosuppressive Agents, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::205fb013faa6bd6daab48657c3ba5c4dTest
https://doi.org/10.1111/bjd.12654Test -
4
المؤلفون: M.E. Otero, J.M.P.A. van den Reek, Jeffrey Zweegers, P.M. Ossenkoppele, Marieke M B Seyger, B.A.M. Sybrandy-Fleuren, R.J.B. Driessen, M.D. Njoo, M.P.M. Andriessen, W.P. Arnold, M.I.A. Koetsier, P.C.M. van de Kerkhof, P.P.M. van Lümig, Wietske Kievit, J.M. Mommers, E.M.G.J. de Jong, A.L.A. Kuijpers
المصدر: British Journal of Dermatology, 171, 5, pp. 1189-96
British Journal of Dermatology, 171, 1189-96مصطلحات موضوعية: Male, musculoskeletal diseases, medicine.medical_specialty, Alzheimer`s disease Radboud Institute for Health Sciences [Radboudumc 1], Dermatology, Kaplan-Meier Estimate, Antibodies, Monoclonal, Humanized, Receptors, Tumor Necrosis Factor, Etanercept, Quality of life, Internal medicine, Psoriasis, Ustekinumab, Adalimumab, Medicine, Humans, Prospective Studies, skin and connective tissue diseases, business.industry, Drug Substitution, Hazard ratio, Dermatology Life Quality Index, Middle Aged, medicine.disease, Treatment Outcome, Patient Satisfaction, Immunoglobulin G, Cohort, Quality of Life, Inflammatory diseases Radboud Institute for Health Sciences [Radboudumc 5], Female, Dermatologic Agents, business, medicine.drug
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca98e86b40060f4f3a92f74d3f0ed5dfTest
https://hdl.handle.net/2066/137707Test -
5Clinical response in psoriasis patients discontinued from and then reinitiated on etanercept therapy
المؤلفون: Alice B. Gottlieb, Angelika Jahreis, Andrea Wang, Ralph Zitnik, Kenneth B. Gordon, Boni E. Elewski, Craig L. Leonardi
المصدر: Journal of Dermatological Treatment. 17:9-17
مصطلحات موضوعية: Adult, Male, musculoskeletal diseases, medicine.medical_specialty, medicine.medical_treatment, macromolecular substances, Dermatology, Gastroenterology, Receptors, Tumor Necrosis Factor, Etanercept, Double-Blind Method, Psoriasis, Internal medicine, medicine, Humans, Immunologic Factors, Etanercept therapy, Chemotherapy, business.industry, Antagonist, Middle Aged, medicine.disease, Surgery, Clinical trial, Treatment Outcome, Cytokine, Withholding Treatment, Immunoglobulin G, Retreatment, Female, Tumor necrosis factor alpha, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a4c03ac89063a2be62dd6cfa9ef84a1aTest
https://doi.org/10.1080/09546630500472838Test -
6
المؤلفون: Amanda Sergay, Sharon E. Jacob, Francisco A. Kerdel
المصدر: International Journal of Dermatology. 44:688-691
مصطلحات موضوعية: Adult, Male, musculoskeletal diseases, medicine.medical_specialty, Adolescent, Dermatology, Disease, Systemic therapy, Receptors, Tumor Necrosis Factor, Etanercept, Internal medicine, Psoriasis, medicine, Humans, In patient, Etanercept therapy, Adverse effect, Aged, Retrospective Studies, Clinical Trials as Topic, business.industry, Moderate to severe psoriasis, Middle Aged, medicine.disease, Surgery, Treatment Outcome, Immunoglobulin G, Female, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d00a13b543e508178c0accde9d1982c9Test
https://doi.org/10.1111/j.1365-4632.2005.02626.xTest -
7
المؤلفون: Bruce Strober
المصدر: Seminars in Cutaneous Medicine and Surgery. 24:28-36
مصطلحات موضوعية: musculoskeletal diseases, medicine.medical_specialty, Dermatology, Receptors, Tumor Necrosis Factor, Etanercept, Proinflammatory cytokine, immune system diseases, Psoriasis, medicine, Humans, Immunologic Factors, Etanercept therapy, skin and connective tissue diseases, Clinical Trials as Topic, business.industry, Remission Induction, medicine.disease, Clinical trial, stomatognathic diseases, Tolerability, Immunoglobulin G, Surgery, Tumor necrosis factor alpha, business, Tumor necrosis factor receptor, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ac005b81f48e799b1a9296fbd4a85cfTest
https://doi.org/10.1016/j.sder.2005.01.003Test -
8
المؤلفون: Evan Kantor, R. Wei, Sumati Rao, Howard G. Birnbaum, Noam Y. Kirson, Mary Cifaldi
المصدر: Journal of Medical Economics. 16:479-489
مصطلحات موضوعية: Adult, Male, musculoskeletal diseases, medicine.medical_specialty, Time Factors, Arthritis, Antibodies, Monoclonal, Humanized, Receptors, Tumor Necrosis Factor, Etanercept, Psoriatic arthritis, Psoriasis, Statistical significance, Internal medicine, medicine, Adalimumab, Humans, skin and connective tissue diseases, Randomized Controlled Trials as Topic, Tumor Necrosis Factor-alpha, business.industry, Health Policy, Arthritis, Psoriatic, Patient Acuity, Antibodies, Monoclonal, Middle Aged, medicine.disease, Dermatology, Infliximab, Clinical trial, Antirheumatic Agents, Immunoglobulin G, Drug Therapy, Combination, Female, Health Expenditures, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19877c13b3a333be24af4ac274083132Test
https://doi.org/10.3111/13696998.2013.768530Test -
9
المؤلفون: Dominique C. van Rappard, Jan R. Mekkes, Jacqueline Limpens
المصدر: Journal of Dermatological Treatment. 24:392-404
مصطلحات موضوعية: musculoskeletal diseases, medicine.medical_specialty, Off-Label Treatment, MEDLINE, Dermatology, Antibodies, Monoclonal, Humanized, Off-label use, Receptors, Tumor Necrosis Factor, Etanercept, law.invention, Randomized controlled trial, law, Adalimumab, medicine, Humans, Hidradenitis suppurativa, skin and connective tissue diseases, Tumor Necrosis Factor-alpha, business.industry, Antibodies, Monoclonal, Off-Label Use, medicine.disease, Infliximab, Hidradenitis Suppurativa, Immunoglobulin G, Dermatologic Agents, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5670f3cc7bbb7253e6ade224e62154eTest
https://doi.org/10.3109/09546634.2012.674193Test -
10
المصدر: Journal of Dermatological Treatment. 24:162-168
مصطلحات موضوعية: Adult, Male, musculoskeletal diseases, medicine.medical_specialty, Dermatology, Antibodies, Monoclonal, Humanized, Single Center, Severity of Illness Index, Receptors, Tumor Necrosis Factor, Etanercept, Nail Diseases, Severity of illness, medicine, Adalimumab, Humans, Psoriasis, skin and connective tissue diseases, Retrospective Studies, Tumor Necrosis Factor-alpha, business.industry, Antibodies, Monoclonal, Psoriatic nails, Retrospective cohort study, Middle Aged, medicine.disease, Infliximab, stomatognathic diseases, Treatment Outcome, Immunoglobulin G, Female, Tumor necrosis factor alpha, Dermatologic Agents, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af5045bf4fc7c960be89e8f200bf4ab3Test
https://doi.org/10.3109/09546634.2011.646939Test